+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Coronary Artery Bypass Graft Devices Market by Product Type, Graft Type, Procedure Type, End User - Global Forecast to 2030- Product Image
Coronary Artery Bypass Graft Devices Market by Product Type, Graft Type, Procedure Type, End User - Global Forecast to 2030- Product Image
Sale

Coronary Artery Bypass Graft Devices Market by Product Type, Graft Type, Procedure Type, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 194 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6014682
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Coronary Artery Bypass Graft Devices Market grew from USD 14.88 billion in 2024 to USD 15.86 billion in 2025. It is expected to continue growing at a CAGR of 6.49%, reaching USD 21.70 billion by 2030.

Setting the Stage for Next-Generation Bypass Devices

Coronary artery bypass grafting (CABG) represents one of the most established and consequential procedures in cardiovascular surgery, serving as a vital lifeline for patients with severe coronary artery disease. Over decades, the devices that facilitate these complex operations have evolved from rudimentary tools to highly engineered systems designed for precision, reliability, and improved clinical outcomes. Today, advances in material science, imaging-guided technologies, and minimally invasive techniques are converging to redefine the standards of care for bypass graft procedures.

As the global population ages and the burden of cardiovascular disease intensifies, the demand for sophisticated bypass devices continues to grow. Surgical teams seek instruments that not only streamline the anastomosis process but also mitigate complications such as graft occlusion, bleeding, and infection. Simultaneously, the rise of off-pump procedures and hybrid revascularization strategies has spurred interest in devices optimized for reduced extracorporeal circulation time and enhanced hemodynamic stability.

In this executive summary, we delve into the transformative forces reshaping the CABG device landscape, examine the impact of trade policies, and uncover key segmentation angles, regional dynamics, and competitive insights. The goal is to equip decision-makers with a clear, actionable perspective on where the market stands today and where it is heading tomorrow.

Technological and Clinical Breakthroughs Redefine Bypass Surgery

The coronary artery bypass graft device sector is undergoing a period of unprecedented change, driven by a fusion of technological breakthroughs and shifting clinical paradigms. Robotics-assisted stabilizers and precision anastomosis rings are now enabling surgeons to perform intricate graft connections with submillimeter accuracy, even in anatomically challenging cases. At the same time, the evolution of portable cardiopulmonary bypass systems has made ambulatory surgical centers a viable setting for select bypass procedures, decentralizing care away from traditional hospital operating rooms.

Simultaneously, imaging-guided navigation platforms are integrating real-time flow measurements and high-definition visualization to guide graft placement and confirm patency intraoperatively. These tools are transforming decision-making on the fly, reducing the need for revision surgeries and lowering overall patient risk. Furthermore, the proliferation of bioresorbable scaffolds and advanced polymer coatings promises to enhance endothelialization and long-term graft durability, potentially redefining best practices in graft selection.

As precision medicine gains traction, patient-specific device customization-driven by preoperative imaging and 3D printing-offers the possibility of tailor-made stabilizers and occluders. This shift from one-size-fits-all to bespoke solutions is poised to elevate procedural efficiency and patient outcomes, ushering in a new era of personalized bypass therapy.

Navigating the Ripple Effects of 2025 U.S. Tariffs on Device Supply

In 2025, the cumulative impact of newly imposed tariffs on medical device imports in the United States has reverberated throughout the global CABG device supply chain. Manufacturers that traditionally relied on cost-competitive components from overseas suppliers faced sudden escalations in raw material and subassembly costs. These added expenses have, in many instances, been absorbed by device makers to remain competitive, albeit at the expense of margin contraction.

Hospitals and surgical centers are feeling the strain as well, encountering higher unit costs for anastomosis rings, clamps, and bypass circuits. Some institutions have responded by renegotiating contracts, exploring alternative domestic suppliers, or adjusting case mix to optimize utilization of existing inventory. Smaller ambulatory centers with lean procurement teams have been particularly vulnerable, prompting discussions about centralized purchasing consortia to leverage greater buying power.

On a strategic level, the tariff-driven cost pressures have accelerated conversations around nearshoring and reshoring of critical manufacturing processes. Several leading suppliers have announced investments in U.S.-based production lines for compression rings and heart-lung machine components. These moves aim to create a more resilient supply chain, mitigate future tariff risks, and maintain stable pricing for end users.

Revealing the Market Through Four Essential Segmentation Lenses

A granular view of the CABG device market reveals distinct dynamics when analyzed across product types, graft choices, procedural approaches, and end-user settings. The product spectrum spans anastomosis devices, cardiopulmonary bypass systems, clamps and occluders, and stabilizers. Within anastomosis devices, compression rings increasingly compete with stapling systems by offering reduced trauma at the vessel interface. Portable heart-lung machines are gaining traction alongside standard machines due to their flexibility in varied clinical environments, while aortic clamps and vascular occluders vie for surgeon preference based on ease of deployment. Mechanical stabilizers remain the workhorse in most operating rooms, though suction-based models are carving out share with minimally invasive teams.

When graft type is considered, arterial conduits such as the internal mammary and radial arteries are commanding growing interest for their superior long-term patency, even as the saphenous vein continues to serve as a dependable venous option in multi-vessel revascularizations. The procedure type segmentation underscores the rise of off-pump techniques, valued for reduced systemic inflammatory responses, balanced against the enduring use of on-pump strategies for complex, multi-graft interventions. Finally, in end-user analysis, hospitals persist as the primary setting for CABG surgeries due to comprehensive infrastructure, while ambulatory surgical centers are capturing incremental volume by capitalizing on streamlined workflows and lower-cost models for selected patient cohorts.

Unearthing Regional Variations That Shape Market Trajectories

Regional dynamics in the CABG device market reflect a tapestry of healthcare infrastructure, reimbursement frameworks, and demographic pressures. In the Americas, robust cardiovascular care networks and high patient awareness sustain steady demand for advanced bypass technologies, with the United States leading adoption of off-pump techniques and hybrid operating theaters. Meanwhile, Canada’s centralized procurement processes influence pricing structures and drive interest in cost-effective surgical adjuncts.

Across Europe, the Middle East, and Africa, heterogeneity in regulatory pathways and reimbursement models yields a fragmented landscape. Western European nations are early adopters of minimally invasive stabilizers and bioresorbable materials, while several Eastern European markets are focusing on expanding basic bypass capabilities to meet rising incidence of coronary disease. In the Middle East and Africa, investment in hospital infrastructure is accelerating, creating opportunities for portable bypass machines and simplified anastomosis systems.

The Asia-Pacific region presents a dual narrative: mature markets such as Japan and Australia exhibit high penetration of premium devices, whereas emerging economies in Southeast Asia and India are witnessing rapid expansion of hospital capacity. Cost-sensitive procurement in these markets is fostering interest in streamlined cardiopulmonary systems and versatile clamps that balance performance with affordability.

Competitive Moves That Define Market Leadership

Key players in the coronary artery bypass graft device space are leveraging their extensive product portfolios and global reach to solidify market positions. One leading innovator has prioritized robotic-assisted stabilizers and integrated imaging platforms, reinforcing its reputation for precision-driven solutions. Another established device manufacturer has doubled down on portable heart-lung machine production, capturing share in ambulatory settings and emerging markets through modular design enhancements.

A third competitor has focused on expanding its anastomosis device suite to include both compression rings and stapling offerings, addressing diverse surgeon preferences under a unified brand. This strategy seeks to streamline product training and procurement for hospital systems. Simultaneously, a specialist in surgical occlusion tools has advanced the material composition of its vascular clamps, reducing vessel trauma and improving user ergonomics, thereby differentiating itself in a crowded segment.

Across the board, these organizations are investing heavily in clinical studies to validate long-term graft patency and procedural efficiency. Their collaborative engagements with academic centers and key opinion leaders are accelerating real-world evidence generation, which in turn bolsters adoption and reinforces value propositions in a cost-sensitive environment.

Charting a Proactive Course for Sustainable Growth

Industry leaders must act decisively to navigate the intersecting pressures of technological change, trade policy, and evolving clinical preferences. First, securing supply chain resilience by diversifying suppliers and investing in localized manufacturing will help mitigate future tariff shocks and raw material constraints. Parallel to this, prioritizing modular device platforms that can be updated with new imaging or robotic interfaces will extend product lifecycles and protect R&D investments.

Second, building strategic alliances with leading cardiac centers and key opinion leaders to co-develop and validate advanced occlusion and anastomosis technologies will accelerate clinical acceptance and generate critical outcomes data. These partnerships should encompass training programs that facilitate surgeon adoption in both hospital and ambulatory environments.

Finally, expanding commercialization efforts in Asia-Pacific and select EMEA markets-through value-based pricing models and tailored financing solutions-can unlock new growth corridors. Embracing digital health enablers such as remote monitoring of postoperative graft performance will further differentiate offerings and support longer-term customer relationships.

Methodological Rigor Underpinning the Market Analysis

This analysis draws upon a robust blend of primary and secondary research methodologies. Primary research involved in-depth interviews with cardiovascular surgeons, procurement specialists, and clinical engineers across key regions, providing firsthand insights into procedural challenges and device preferences. Secondary research leveraged peer-reviewed journals, regulatory filings, company annual reports, and conference proceedings to build a comprehensive view of technological trends and competitive landscapes.

Data validation processes included cross-referencing responses from multiple stakeholders to ensure consistency and reliability. Case studies were examined to quantify the impact of innovations such as suction stabilizers and bioresorbable anastomosis rings on surgical outcomes. Market dynamics, including the effects of tariff adjustments, were analyzed through the lens of trade statistics and public policy announcements.

This triangulated approach ensures that the findings and recommendations presented herein are grounded in both empirical evidence and expert opinion, offering a credible foundation for strategic decision-making.

Synthesizing Insights to Shape the Future of Bypass Therapy

The coronary artery bypass graft device market stands at an inflection point, shaped by rapid technological advancement, shifting policy environments, and evolving procedural standards. As robotics, imaging integration, and precision materials redefine surgical capabilities, the competitive landscape is becoming both more dynamic and more demanding. Companies that embrace modular product architectures, forge collaborative clinical partnerships, and fortify their supply chains will be best positioned to capture the opportunities ahead.

Regional nuances in adoption patterns underscore the importance of tailored strategies: cost-efficient solutions resonate in emerging markets, while premium offerings drive differentiation in established healthcare systems. The ripple effects of recent tariff changes further highlight the imperative for supply chain diversity and local manufacturing agility.

By synthesizing these insights, stakeholders can anticipate market developments and align their innovation roadmaps to meet the dual imperatives of enhanced patient outcomes and sustainable business performance. In doing so, they will help chart the course for the next era of bypass surgery excellence.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Anastomosis Devices
      • Compression Anastomosis Rings
      • Stapling Devices
    • Cardiopulmonary Bypass Systems
      • Portable Systems
      • Standard Heart-Lung Machines
    • Clamps & Occluders
      • Aortic Clamps
      • Vascular Occluders
    • Stabilizers
      • Mechanical Stabilizers
      • Suction Stabilizers
  • Graft Type
    • Arterial Grafts
      • Internal Mammary Artery
      • Radial Artery
    • Venous Grafts
      • Saphenous Vein
  • Procedure Type
    • Off-Pump
    • On-Pump
  • End User
    • Ambulatory Surgical Centers
    • Hospitals
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Medtronic plc
  • Abbott Laboratories
  • Johnson & Johnson
  • Terumo Corporation
  • B. Braun Melsungen AG
  • Getinge AB
  • LivaNova PLC
  • CryoLife, Inc.
  • Teleflex Incorporated
  • AtriCure, Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Coronary Artery Bypass Graft Devices Market, by Product Type
8.1. Introduction
8.2. Anastomosis Devices
8.2.1. Compression Anastomosis Rings
8.2.2. Stapling Devices
8.3. Cardiopulmonary Bypass Systems
8.3.1. Portable Systems
8.3.2. Standard Heart-Lung Machines
8.4. Clamps & Occluders
8.4.1. Aortic Clamps
8.4.2. Vascular Occluders
8.5. Stabilizers
8.5.1. Mechanical Stabilizers
8.5.2. Suction Stabilizers
9. Coronary Artery Bypass Graft Devices Market, by Graft Type
9.1. Introduction
9.2. Arterial Grafts
9.2.1. Internal Mammary Artery
9.2.2. Radial Artery
9.3. Venous Grafts
9.3.1. Saphenous Vein
10. Coronary Artery Bypass Graft Devices Market, by Procedure Type
10.1. Introduction
10.2. Off-Pump
10.3. On-Pump
11. Coronary Artery Bypass Graft Devices Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Hospitals
12. Americas Coronary Artery Bypass Graft Devices Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Coronary Artery Bypass Graft Devices Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Coronary Artery Bypass Graft Devices Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Medtronic plc
15.3.2. Abbott Laboratories
15.3.3. Johnson & Johnson
15.3.4. Terumo Corporation
15.3.5. B. Braun Melsungen AG
15.3.6. Getinge AB
15.3.7. LivaNova PLC
15.3.8. CryoLife, Inc.
15.3.9. Teleflex Incorporated
15.3.10. AtriCure, Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. CORONARY ARTERY BYPASS GRAFT DEVICES MARKET MULTI-CURRENCY
FIGURE 2. CORONARY ARTERY BYPASS GRAFT DEVICES MARKET MULTI-LANGUAGE
FIGURE 3. CORONARY ARTERY BYPASS GRAFT DEVICES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. CORONARY ARTERY BYPASS GRAFT DEVICES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COMPRESSION ANASTOMOSIS RINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STAPLING DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PORTABLE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STANDARD HEART-LUNG MACHINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY AORTIC CLAMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VASCULAR OCCLUDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY MECHANICAL STABILIZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY SUCTION STABILIZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY INTERNAL MAMMARY ARTERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY RADIAL ARTERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VENOUS GRAFTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY SAPHENOUS VEIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VENOUS GRAFTS, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY OFF-PUMP, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ON-PUMP, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VENOUS GRAFTS, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VENOUS GRAFTS, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 59. CANADA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 60. CANADA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2030 (USD MILLION)
TABLE 61. CANADA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 62. CANADA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2030 (USD MILLION)
TABLE 63. CANADA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2030 (USD MILLION)
TABLE 64. CANADA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 65. CANADA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2030 (USD MILLION)
TABLE 66. CANADA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VENOUS GRAFTS, 2018-2030 (USD MILLION)
TABLE 67. CANADA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 68. CANADA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 69. MEXICO CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 70. MEXICO CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2030 (USD MILLION)
TABLE 71. MEXICO CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 72. MEXICO CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2030 (USD MILLION)
TABLE 73. MEXICO CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2030 (USD MILLION)
TABLE 74. MEXICO CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 75. MEXICO CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2030 (USD MILLION)
TABLE 76. MEXICO CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VENOUS GRAFTS, 2018-2030 (USD MILLION)
TABLE 77. MEXICO CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 78. MEXICO CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VENOUS GRAFTS, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VENOUS GRAFTS, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VENOUS GRAFTS, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 110. UNITED KINGDOM CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 111. UNITED KINGDOM CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2030 (USD MILLION)
TABLE 112. UNITED KINGDOM CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 113. UNITED KINGDOM CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2030 (USD MILLION)
TABLE 114. UNITED KINGDOM CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2030 (USD MILLION)
TABLE 115. UNITED KINGDOM CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 116. UNITED KINGDOM CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2030 (USD MILLION)
TABLE 117. UNITED KINGDOM CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VENOUS GRAFTS, 2018-2030 (USD MILLION)
TABLE 118. UNITED KINGDOM CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 119. UNITED KINGDOM CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. GERMANY CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 121. GERMANY CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2030 (USD MILLION)
TABLE 122. GERMANY CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 123. GERMANY CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2030 (USD MILLION)
TABLE 124. GERMANY CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2030 (USD MILLION)
TABLE 125. GERMANY CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 126. GERMANY CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2030 (USD MILLION)
TABLE 127. GERMANY CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VENOUS GRAFTS, 2018-2030 (USD MILLION)
TABLE 128. GERMANY CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 129. GERMANY CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. FRANCE CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 131. FRANCE CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2030 (USD MILLION)
TABLE 132. FRANCE CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 133. FRANCE CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2030 (USD MILLION)
TABLE 134. FRANCE CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2030 (USD MILLION)
TABLE 135. FRANCE CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 136. FRANCE CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2030 (USD MILLION)
TABLE 137. FRANCE CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VENOUS GRAFTS, 2018-2030 (USD MILLION)
TABLE 138. FRANCE CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 139. FRANCE CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. RUSSIA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 141. RUSSIA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2030 (USD MILLION)
TABLE 142. RUSSIA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 143. RUSSIA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2030 (USD MILLION)
TABLE 144. RUSSIA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2030 (USD MILLION)
TABLE 145. RUSSIA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 146. RUSSIA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2030 (USD MILLION)
TABLE 147. RUSSIA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VENOUS GRAFTS, 2018-2030 (USD MILLION)
TABLE 148. RUSSIA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 149. RUSSIA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 150. ITALY CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 151. ITALY CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2030 (USD MILLION)
TABLE 152. ITALY CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 153. ITALY CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2030 (USD MILLION)
TABLE 154. ITALY CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2030 (USD MILLION)
TABLE 155. ITALY CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 156. ITALY CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2030 (USD MILLION)
TABLE 157. ITALY CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VENOUS GRAFTS, 2018-2030 (USD MILLION)
TABLE 158. ITALY CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 159. ITALY CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 160. SPAIN CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 161. SPAIN CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2030 (USD MILLION)
TABLE 162. SPAIN CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 163. SPAIN CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2030 (USD MILLION)
TABLE 164. SPAIN CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2030 (USD MILLION)
TABLE 165. SPAIN CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 166. SPAIN CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2030 (USD MILLION)
TABLE 167. SPAIN CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VENOUS GRAFTS, 2018-2030 (USD MILLION)
TABLE 168. SPAIN CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 169. SPAIN CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 170. UNITED ARAB EMIRATES CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 171. UNITED ARAB EMIRATES CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2030 (USD MILLION)
TABLE 172. UNITED ARAB EMIRATES CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 173. UNITED ARAB EMIRATES CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2030 (USD MILLION)
TABLE 174. UNITED ARAB EMIRATES CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2030 (USD MILLION)
TABLE 175. UNITED ARAB EMIRATES CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 176. UNITED ARAB EMIRATES CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2030 (USD MILLION)
TABLE 177. UNITED ARAB EMIRATES CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VENOUS GRAFTS, 2018-2030 (USD MILLION)
TABLE 178. UNITED ARAB EMIRATES CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 179. UNITED ARAB EMIRATES CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 180. SAUDI ARABIA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 181. SAUDI ARABIA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2030 (USD MILLION)
TABLE 182. SAUDI ARABIA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 183. SAUDI ARABIA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2030 (USD MILLION)
TABLE 184. SAUDI ARABIA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2030 (USD MILLION)
TABLE 185. SAUDI ARABIA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 186. SAUDI ARABIA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2030 (USD MILLION)
TABLE 187. SAUDI ARABIA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VENOUS GRAFTS, 2018-2030 (USD MILLION)
TABLE 188. SAUDI ARABIA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 189. SAUDI ARABIA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 190. SOUTH AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 191. SOUTH AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2030 (USD MILLION)
TABLE 192. SOUTH AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 193. SOUTH AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2030 (USD MILLION)
TABLE 194. SOUTH AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2030 (USD MILLION)
TABLE 195. SOUTH AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 196. SOUTH AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2030 (USD MILLION)
TABLE 197. SOUTH AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VENOUS GRAFTS, 2018-2030 (USD MILLION)
TABLE 198. SOUTH AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 200. DENMARK CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 201. DENMARK CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2030 (USD MILLION)
TABLE 202. DENMARK CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 203. DENMARK CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2030 (USD MILLION)
TABLE 204. DENMARK CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2030 (USD MILLION)
TABLE 205. DENMARK CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 206. DENMARK CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2030 (USD MILLION)
TABLE 207. DENMARK CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VENOUS GRAFTS, 2018-2030 (USD MILLION)
TABLE 208. DENMARK CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 209. DENMARK CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 210. NETHERLANDS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 211. NETHERLANDS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2030 (USD MILLION)
TABLE 212. NETHERLANDS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 213. NETHERLANDS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2030 (USD MILLION)
TABLE 214. NETHERLANDS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2030 (USD MILLION)
TABLE 215. NETHERLANDS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 216. NETHERLANDS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2030 (USD MILLION)
TABLE 217. NETHERLANDS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VENOUS GRAFTS, 2018-2030 (USD MILLION)
TABLE 218. NETHERLANDS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 219. NETHERLANDS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 220. QATAR CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 221. QATAR CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2030 (USD MILLION)
TABLE 222. QATAR CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 223. QATAR CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2030 (USD MILLION)
TABLE 224. QATAR CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2030 (USD MILLION)
TABLE 225. QATAR CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 226. QATAR CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2030 (USD MILLION)
TABLE 227. QATAR CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VENOUS GRAFTS, 2018-2030 (USD MILLION)
TABLE 228. QATAR CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 229. QATAR CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 230. FINLAND CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 231. FINLAND CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2030 (USD MILLION)
TABLE 232. FINLAND CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 233. FINLAND CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2030 (USD MILLION)
TABLE 234. FINLAND CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2030 (USD MILLION)
TABLE 235. FINLAND CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 236. FINLAND CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2030 (USD MILLION)
TABLE 237. FINLAND CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VENOUS GRAFTS, 2018-2030 (USD MILLION)
TABLE 238. FINLAND CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 239. FINLAND CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 240. SWEDEN CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 241. SWEDEN CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2030 (USD MILLION)
TABLE 242. SWEDEN CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 243. SWEDEN CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2030 (USD MILLION)
TABLE 244. SWEDEN CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2030 (USD MILLION)
TABLE 245. SWEDEN CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 246. SWEDEN CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2030 (USD MILLION)
TABLE 247. SWEDEN CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VENOUS GRAFTS, 2018-2030 (USD MILLION)
TABLE 248. SWEDEN CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 249. SWEDEN CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 250. NIGERIA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 251. NIGERIA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2030 (USD MILLION)
TABLE 252. NIGERIA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 253. NIGERIA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2030 (USD MILLION)
TABLE 254. NIGERIA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2030 (USD MILLION)
TABLE 255. NIGERIA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 256. NIGERIA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2030 (USD MILLION)
TABLE 257. NIGERIA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VENOUS GRAFTS, 2018-2030 (USD MILLION)
TABLE 258. NIGERIA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 259. NIGERIA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 260. EGYPT CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 261. EGYPT CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2030 (USD MILLION)
TABLE 262. EGYPT CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 263. EGYPT CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2030 (USD MILLION)
TABLE 264. EGYPT CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2030 (USD MILLION)
TABLE 265. EGYPT CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 266. EGYPT CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2030 (USD MILLION)
TABLE 267. EGYPT CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VENOUS GRAFTS, 2018-2030 (USD MILLION)
TABLE 268. EGYPT CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 269. EGYPT CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 270. TURKEY CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 271. TURKEY CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2030 (USD MILLION)
TABLE 272. TURKEY CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 273. TURKEY CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2030 (USD MILLION)
TABLE 274. TURKEY CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2030 (USD MILLION)
TABLE 275. TURKEY CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 276. TURKEY CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2030 (USD MILLION)
TABLE 277. TURKEY CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VENOUS GRAFTS, 2018-2030 (USD MILLION)
TABLE 278. TURKEY CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 279. TURKEY CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 280. ISRAEL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 281. ISRAEL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2030 (USD MILLION)
TABLE 282. ISRAEL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 283. ISRAEL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2030 (USD MILLION)
TABLE 284. ISRAEL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2030 (USD MILLION)
TABLE 285. ISRAEL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 286. ISRAEL CORONARY ARTERY BYPASS GRAFT DE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Coronary Artery Bypass Graft Devices market report include:
  • Medtronic plc
  • Abbott Laboratories
  • Johnson & Johnson
  • Terumo Corporation
  • B. Braun Melsungen AG
  • Getinge AB
  • LivaNova PLC
  • CryoLife, Inc.
  • Teleflex Incorporated
  • AtriCure, Inc.

Table Information

Report AttributeDetails
No. of Pages194
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 15.86 Billion
Forecasted Market Value ( USD ) by 2030 $ 21.7 Billion
Compound Annual Growth Rate6.4%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Coronary Artery Bypass Grafts Market by Graft Type, Procedure Type, End User, Application - Global Forecast to 2030 - Product Image

Coronary Artery Bypass Grafts Market by Graft Type, Procedure Type, End User, Application - Global Forecast to 2030

  • Report
  • 185 Pages
  • Global
From
Coronary Artery Bypass Graft Market Report 2025 - Product Image

Coronary Artery Bypass Graft Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Coronary Artery Bypass Grafts (CABG) - Global Strategic Business Report - Product Image

Coronary Artery Bypass Grafts (CABG) - Global Strategic Business Report

  • Report
  • 176 Pages
  • Global
From
Coronary Artery Bypass Graft Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Coronary Artery Bypass Graft Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 190 Pages
  • Global
From
Coronary Artery Bypass Graft Surgery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update - Product Image

Coronary Artery Bypass Graft Surgery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  • Report
  • 55 Pages
  • Global
From

About the Coronary Artery Bypass Graft Device Market

The Coronary Artery Bypass Graft (CABG) Device market is a segment of the Cardiovascular Devices industry. CABG Devices are used to treat coronary artery disease, a condition in which the arteries that supply blood to the heart become blocked or narrowed. These devices are used to bypass the blocked or narrowed artery, allowing blood to flow freely to the heart. CABG Devices include grafts, stents, and other devices used to perform the procedure. The CABG Device market is driven by the increasing prevalence of coronary artery disease, as well as advances in technology that have improved the safety and efficacy of the procedure. The market is also driven by the increasing demand for minimally invasive procedures, such as robotic-assisted CABG. Some of the major companies in the CABG Device market include Medtronic, Abbott, Boston Scientific, Edwards Lifesciences, and Terumo. These companies offer a wide range of CABG Devices, including grafts, stents, and other devices used to perform the procedure. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.